(Q28287744)

English

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study (English)

0 references

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

0 references

object named as

Steven Hawken

2

0 references

12

object named as

Salim Yusuf

0 references

Allan D Sniderman

5

object named as

Allan Sniderman

0 references

Jeffrey L Probstfield

6

object named as

Jeffrey Probstfield

0 references

author name string

Matthew J McQueen

1

0 references

Xingyu Wang

3

0 references

Stephanie Ounpuu

4

0 references

Krisela Steyn

7

0 references

John E Sanderson

8

0 references

Mohammad Hasani

9

0 references

Emilia Volkova

10

0 references

Khawar Kazmi

11

0 references

language of work or name

0 references

publication date

19 July 2008

0 references

0 references

372

0 references

9634

0 references

224-33

0 references

INTER-HEART: A global study of risk factors for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary heart disease attack rate, incidence and mortality 1975-1994 in Göteborg, Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Population attributable risks of esophageal and gastric cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential impact of plasma triglycerides on HDL-cholesterol and HDL-apo A-I in a large cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961076-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(08)61076-4

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28287744&oldid=2152921482"